Single-cell analyses identify dysfunctional CD16<sup>+</sup> CD8 T cells in smokers.

Martos, Suzanne N; Campbell, Michelle R; Lozoya, Oswaldo A; Wang, Xuting; Bennett, Brian D; Thompson, Isabel J B; Wan, Ma; Pittman, Gary S et al. · Cell Rep Med · 2020

cross_sectional · Level IV

Where this comes from

Abstract

Tobacco smoke exposure contributes to the global burden of communicable and chronic diseases. To identify immune cells affected by smoking, we use single-cell RNA sequencing on peripheral blood from smokers and nonsmokers. Transcriptomes reveal a subpopulation of <i>FCGR3A</i> (CD16)-expressing Natural Killer (NK)-like CD8 T lymphocytes that increase in smokers. Mass cytometry confirms elevated CD16<sup>+</sup> CD8 T cells in smokers. Inferred as highly differentiated by pseudotime analysis, NK-like CD8 T cells express markers characteristic of effector memory re-expressing CD45RA T (T<sub>EMRA</sub>) cells. Indicative of immune aging, smokers' CD8 T cells are biased toward differentiated cells and smokers have fewer naïve cells than nonsmokers. DNA methylation-based models show that smoking dose is associated with accelerated aging and decreased telomere length, a biomarker of T cell senescence. Immune aging accompanies T cell senescence, which can ultimately lead to impaired immune function. This suggests a role for smoking-induced, senescence-associated immune dysregulation in smoking-mediated pathologies.

Medical subject headings